Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Earnings Scheduled For February 2, 2022
Companies Reporting Before The Bell
• Sony Group (NYSE:SONY) is likely to report quarterly earnings at $1.57 per share on revenue of $24.59 billion.
A Preview Of Central Garden & Pet’s Earnings
Central Garden & Pet (NASDAQ:CENTA) is set to give its latest quarterly earnings report on Wednesday, 2022-02-02. Here's what investors need to know before the announcement.
Analysts estimate that Central Garden & Pet will likely report an Earnings Per Share (EPS) of $0.05.
Mid-Afternoon Market Update: DocuSign Drops Following Weak Revenue Forecast; Longeveron Shares Climb
Toward the end of trading Friday, the Dow traded down 0.37% to 34,512.05 while the NASDAQ fell 2.28% to 15,029.99. The S&P also fell, dropping 1.13% to 4,525.40.
56 Biggest Movers From Yesterday
Gainers
Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
Recap: Central Garden & Pet Q4 Earnings
Central Garden & Pet (NASDAQ:CENTA) reported its Q4 earnings results on Monday, November 22, 2021 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For November 22, 2021
Companies Reporting Before The Bell
• Cerence (NASDAQ:CRNC) is estimated to report quarterly earnings at $0.56 per share on revenue of $97.92 million.
Earnings Outlook For Central Garden & Pet
Central Garden & Pet (NASDAQ:CENTA) is set to give its latest quarterly earnings report on Monday, 2021-11-22. Here's what investors need to know before the announcement.
Analysts estimate that Central Garden & Pet will likely report an Earnings Per Share (EPS) of $-0.24
Central Garden & Pet Q3 EPS $1.37 Beats $1.02 Estimate, Sales $1.04B Beat $922.87M Estimate
Central Garden & Pet (NASDAQ:CENT) reported quarterly earnings of $1.37 per share which beat the analyst consensus estimate of $1.02 by 34.31 percent. This is a 3.79 percent increase over earnings of $1.32 per share from
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.